New York, January 17, 2013 -- Stryker Corporation (A3 stable) announced on 17 January that it plans to acquire the Trauson Holdings Company Limited (unrated), a leading manufacturer of orthopedic trauma and spine products in China, for about $685 million, net of balance sheet cash. The acquisition is credit positive because we expect Stryker to use offshore cash rather than debt to acquire a business that will better position Stryker as a player in an important emerging market. However, because Stryker will not see material positive effects from this transaction over the near term, the ratings are not affected at this time. For additional information, please refer to Moody's Issuer Comment on Stryker available at Moodys.com.

Vollständigen Artikel bei Moodys lesen